Compounds > flurbiprofen

flurbiprofen and mocetinostat

flurbiprofen has been researched along with mocetinostat in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibson, K; Kantoci, D; Leipold, D; Liu, Y; McCracken, JD; Mineyama, Y; Murray, ED; Quiggle, D; Wechter, WJ1
Bertrand, V; Chaussade, S; Chauvelot-Moachon, L; Couturier, D; Giroud, JP; Guimbaud, R; Lamrani, A; Mauprivez, C; Sogni, P1
Antonelli, E; Cirino, G; Coata, G; Distrutti, E; Federici, B; Fiorucci, S; Morelli, A; Morelli, O; Renzo, GD; Santucci, L; Soldato, PD1
Kato, S; Kunikata, T; Miyazawa, T; Takeuchi, K; Tanaka, A1
Bhatia, M; Huang, J; Moochhala, SM; Moore, PK1
Dong, L; Jurban, BJ; Sharma, NP; Smith, WL1

Other Studies

6 other study(ies) available for flurbiprofen and mocetinostat

ArticleYear
Mechanism of enhancement of intestinal ulcerogenicity of S-aryl propionic acids by their R-enantiomers in the rat.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flurbiprofen; Intestinal Diseases; Intestinal Mucosa; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Stereoisomerism; Ulcer

1998
Role of tumour necrosis factor-alpha and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity.
    European journal of pharmacology, 1998, Sep-04, Volume: 356, Issue:2-3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Intestine, Small; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ulcer

1998
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Cell Line; Cysteine Proteinase Inhibitors; DNA Fragmentation; Endothelium, Vascular; Flurbiprofen; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitric Oxide; Peroxidase; Rats; Rats, Wistar

1999
Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
    Digestion, 2002, Volume: 66, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dinoprostone; Flurbiprofen; Gastrointestinal Motility; Indomethacin; Intestinal Mucosa; Intestine, Small; Male; Naproxen; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley

2002
Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury.
    Shock (Augusta, Ga.), 2005, Volume: 24, Issue:2

    Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Gastric Mucosa; Inflammation; Lung; Lung Injury; Male; Mice; Neutrophils; Nitric Oxide; Pancreas; Pancreatitis; Peroxidase; Sepsis; Time Factors

2005
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
    The Journal of biological chemistry, 2013, Oct-04, Volume: 288, Issue:40

    Topics: Acetylation; Amino Acid Sequence; Amino Acid Substitution; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Flurbiprofen; Guanidine; Heme; Humans; Indomethacin; Kinetics; Models, Biological; Mutant Proteins; Mutation; Naproxen; Oxygen; Palmitic Acid; Peroxidase; Protein Multimerization; Pyrazoles; Substrate Specificity; Sulfonamides

2013